[
  {
    "ts": "2025-11-29T00:44:59+00:00",
    "headline": "Eli Lilly (LLY) Valuation in Focus After Hitting $1 Trillion on Obesity Drug Breakthroughs",
    "summary": "Eli Lilly (LLY) just crossed a $1 trillion market cap, capturing attention on Wall Street as diabetes and weight-loss drugs continue to propel the company’s value. Demand for its GLP-1 therapies, such as Zepbound and Mounjaro, has surged, due in part to strong clinical trial results and wider coverage from Medicare and Medicaid. See our latest analysis for Eli Lilly. Shares in Eli Lilly have soared over the past year, with momentum building thanks to breakthrough obesity and diabetes drug...",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-valuation-focus-004459479.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "227b4334-3e03-3bab-946a-63dc14963171",
      "content": {
        "id": "227b4334-3e03-3bab-946a-63dc14963171",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Valuation in Focus After Hitting $1 Trillion on Obesity Drug Breakthroughs",
        "description": "",
        "summary": "Eli Lilly (LLY) just crossed a $1 trillion market cap, capturing attention on Wall Street as diabetes and weight-loss drugs continue to propel the company’s value. Demand for its GLP-1 therapies, such as Zepbound and Mounjaro, has surged, due in part to strong clinical trial results and wider coverage from Medicare and Medicaid. See our latest analysis for Eli Lilly. Shares in Eli Lilly have soared over the past year, with momentum building thanks to breakthrough obesity and diabetes drug...",
        "pubDate": "2025-11-29T00:44:59Z",
        "displayTime": "2025-11-29T00:44:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-valuation-focus-004459479.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-valuation-focus-004459479.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]